Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RET proto-oncogene encodes a receptor tyrosine kinase crucial for neural crest development and maintenance. Upon ligand binding, RET dimerizes and activates intracellular signaling pathways regulating cell differentiation, growth, migration, and survival. RET is implicated in various diseases, including Hirschsprung's disease (loss-of-function) and multiple endocrine neoplasias and cancers (gain-of-function).
RET inhibitors block the tyrosine kinase activity of the RET receptor, preventing downstream signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proto-oncogene protein c-ret (RET).